How much funding has Cellular Origins raised?

Cellular Origins has raised $40.0M in total funding, most recently a Series A round.

When was Cellular Origins founded?

Cellular Origins was founded in 2022.

Where is Cellular Origins headquartered?

Cellular Origins is headquartered in Melbourn, United Kingdom.

What industry is Cellular Origins in?

Cellular Origins operates in Biotech, Healthcare.

How many employees does Cellular Origins have?

Cellular Origins has 11-50 employees.

Cellular Origins

Q: Who are Cellular Origins's investors?

Cellular Origins's investors include Johnson & Johnson Innovation, Highland Europe, NYBC Ventures, TTP Ventures, BGF.

Enabling cell therapy manufacture at scale

Melbourn, United Kingdom · Founded 2022 · $40.0M raised

Biotech

Healthcare

Headquarters: Melbourn
Employees: 11–50
Founded: 2022
Business Model: B2B

Website: cellularorigins.com
Total Funding: $40.0M
Last Round: $40.0M Series ADec 2025
Rounds: 1

About

Cellular Origins is enabling the manufacture of cell therapies at scale by combining robotics, AI, and deep bioprocess expertise. The company's flagship product, Constellation, is a mobile robotic ecosystem that fully automates cell therapy manufacturing processes — from clinical to commercial scale — while integrating the existing technologies and equipment that therapy developers already use. Based in Melbourn, UK and founded in 2022 as a TTP Company, Cellular Origins works with leading CDMOs and pharmaceutical partners including Johnson & Johnson to industrialize CAR-T and other cell therapy workflows, reducing labor by 16x and lowering cost of goods by 51%.

Summary

Cellular Origins is a Biotech company based in Melbourn, United Kingdom, founded in 2022. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Dec 2025. Investors include Johnson & Johnson Innovation, Highland Europe and NYBC Ventures.